drugset
drugset / Trial / NCT03581916

A Study to Investigate the Whole Body Distribution and Radiation Dosimetry of the Positron Emission Tomography Ligand Fluoride-18 (18F)-JNJ-64326067 in Healthy Participants

NCT03581916 ↗

Phase 1 Completed 6 enrolled Janssen Research & Development, LLC
NaSingle-groupOpen-labelBasic science

Summary

The purpose of this study is to measure the whole-body distribution and radiation dosimetry of 18F-JNJ-64326067 in healthy participants.

Timeline

Start
2018-07-11
Primary completion
2018-11-02
Completion
2018-11-02

Drugs

EvaluationDrugModalityDoseRoute
Subject 18F-JNJ-64326067 Unknown 185 mbq Intravenous
Subject 18F-JNJ-64326067 Unknown 370 mbq Intravenous

Indications

No indication recorded.